A bill to amend title 35, United States Code, to permit separate patent extensions for each product under a patent which is subject to full regulatory review and approval.
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in senate (Aug 11, 1988)
Amends Federal law regarding extensions of pharmaceutical patent terms to permit a separate extension for a product subject to a regulatory review period before it is put into commerce if the patent claim covers more than one: (1) product; (2) method of product use; or (3) product manufacturing method.
Precludes the use of such extensions for a product other than the one for which the extension is sought.
What just happenedAug 22, 1988
Referred to Subcommittee on Patents, Copyrights and Trademarks.
Who’s behind it
- Aug 22, 1988Committee
Referred to Subcommittee on Patents, Copyrights and Trademarks.
Patents, Copyrights and Trademarks Subcommittee - Aug 11, 1988IntroReferral
Read twice and referred to the Committee on Judiciary.
Judiciary Committee - Aug 11, 1988IntroReferral10000
Introduced in Senate